Controlling ligand density on nanoparticles as a means to enhance biological activity

Nanomedicine

Volumn 10, Issue 2, 2015, Pages 177-180

  Lee, Hyojin ^a   Odom, Teri W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cancer therapy; cellular uptake; drug delivery; functionalization of nanoparticles; gold nanoparticle; ligand density

Indexed keywords

LIGAND; NANOPARTICLE;

BIOLOGICAL ACTIVITY; CANCER THERAPY; DENSITY; DRUG DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; NANOENGINEERING; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY;

ANIMALS; HUMANS; LIGANDS; NANOPARTICLES;

EID: 84921462859     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.204     Document Type: Review

References (20)

1. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63, 185-198 (2012).
2. Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543-557 (2009).
3. Salvati A, Aberg C, dos Santos T et al. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine 7, 818-826 (2011).
4. Tang PS, Sathiamoorthy S, Lustig LC et al. The role of ligand density and size in mediating quantum dot nuclear transport. Small 10, 4182-4192 (2014).
5. Toy R, Peiris PM, Ghaghada KB, Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine 9, 121-134 (2013).
6. Salaita K1, Nair PM, Petit RS et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380-1385 (2010).
7. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857-902 (2009).
8. Dam DHM, Lee RC, Odom TW. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer. Nano Lett. 14, 2843-2848 (2014).
9. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem. Soc. Rev. 41, 2256-2282 (2012).
10. Bagalkot V, Yu MK, Jon S. Nanoparticles for combined cancer imaging and therapy. In: Nanoplatform-Based Molecular Imaging. Xiaoyuan Chen (Ed.). John Wiley & Sons, Inc., NJ, USA, 565-592 (2011).
11. Elias DR, Poloukhtine A, Popik V, Tsourkas A. Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine 9, 194-201 (2013).
12. Giljohann DA,Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA, Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. Engl. 49, 3280-3294 (2010).
13. Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537-550 (2010).
14. Hill HD, Millstone JE, Banholzer MJ, Mirkin CA. The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano 3, 418-424 (2009).
15. Hurst SJ, Lytton-Jean AKR, Mirkin CA. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem. 78, 8313-8318 (2006).
16. Gu F, Zhang L, Teply BA et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl Acad. Sci. USA 105, 2586-2591 (2008).
17. Zhang X, Servos MR, Liu J. Instantaneous and quantitative functionalization of gold nanoparticles with thiolated DNA using a pH-assisted and surfactant-free route. J. Am. Chem. Soc. 134, 7266-7269 (2012).
18. Sajanlal PR, Sreeprasad TS, Samal AK, Pradeep T. Anisotropic nanomaterials: structure, growth, assembly, and functions. Nano Rev. 2, 3402/nano.v2iO.5883 (2011).
19. Giljohann DA, Seferos DS, Patel PC, Millstone JE, Rosi NL, Mirkin CA. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 7, 3818-3821 (2007).
20. Dai Q, Walkey C, Chan WCW. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew. Chem. Int. Ed. Engl. 53, 5093-5096 (2014).